Ankylosing Spondylitis
Pipeline by Development Stage
Drug Modality Breakdown
On Market (4)
Approved therapies currently available
Competitive Landscape
13 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 10,823 patients across 50 trials
Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA
The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)
Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept
Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis
Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis
Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients
Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects
Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
Remission Induction in Very Early Rheumatoid Arthritis
Extension Study Evaluating Etanercept in Ankylosing Spondylitis
Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept
Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis
Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis
Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects
Study Evaluating the Efficacy and Safety of Etanercept
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy
STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis
Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects
Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)
Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept
A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis
Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis
Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid Arthritis
Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis
An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)
Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study
Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis
Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis
Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis
ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis
A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis
A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis
A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis
Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)
Study Evaluating Etanercept in Moderate to Severe Asthma
Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study
An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1
Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)
Study Evaluating Enbrel Drug Levels in Healthy Male Chinese Subjects
Study Evaluating Etanercept 25mg or 50mg Administered Subcutaneously to Healthy Chinese Male Subjects
Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.
A Study to Learn About the Adherence and Clinical Outcomes in Colombian Patients With an E-Device for Etanercept Administration in Rheumatoid Arthritis
Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
Investigating the Use of Salaso to Improve Physiotherapy Management of Ankylosing Spondylitis (AS).
The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis